PARIS (Reuters) – French diagnostics company Eurofins Technologies announced on Wednesday the launch of new devices aimed at testing for the presence of COVID-19, the respiratory disease caused by the coronavirus.
The new, rapid point-of-care testing devices aim to identify a person’s past exposure to the virus, SARS-CoV-2, in 10 minutes, Eurofins said.
Its serology-based, finger-prick tests would detect virus antibodies with a sensitivity of 94.5% from 19 days after symptoms showed, it added.
(Reporting by Sudip Kar-Gupta; Editing by Clarence Fernandez)
